Literature DB >> 21463396

Multidrug-resistant pneumococci (serotype 8) causing invasive disease in HIV+ patients.

J C Sanz1, E Cercenado, M Marín, B Ramos, C Ardanuy, I Rodríguez-Avial, E Bouza.   

Abstract

From July 2007 to June 2009, all pneumococci causing invasive pneumococcal disease in our hospital were serotyped. Antimicrobial susceptibility was determined by microdilution. Molecular typing was performed by pulsed-field gel electrophoresis and by multilocus sequence typing. Among 251 invasive pneumococci, serotype 8 was the most frequent (13.5%). All serotype 8 strains were susceptible to penicillin; however, 61.8% (21/34) were co-resistant to erythromycin, levofloxacin and tetracycline and identical to the Sweden(15A) -ST63 clone. Serotype 8 was significantly more frequent among human immunodeficiency virus (HIV)-infected patients (36.5%). The high prevalence of this non-conjugate vaccine multiresistant serotype 8 is a cause for concern mainly in HIV-infected patients.
© 2011 The Authors. Clinical Microbiology and Infection © 2011 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21463396     DOI: 10.1111/j.1469-0691.2011.03495.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  15 in total

1.  Fluoroquinolone-resistant pneumococci: dynamics of serotypes and clones in Spain in 2012 compared with those from 2002 and 2006.

Authors:  Arnau Domenech; Jose M Tirado-Vélez; Asunción Fenoll; Carmen Ardanuy; Jose Yuste; Josefina Liñares; Adela G de la Campa
Journal:  Antimicrob Agents Chemother       Date:  2014-02-10       Impact factor: 5.191

2.  A semisynthetic Streptococcus pneumoniae serotype 8 glycoconjugate vaccine.

Authors:  Benjamin Schumann; Heung Sik Hahm; Sharavathi G Parameswarappa; Katrin Reppe; Annette Wahlbrink; Subramanian Govindan; Paulina Kaplonek; Liise-Anne Pirofski; Martin Witzenrath; Chakkumkal Anish; Claney L Pereira; Peter H Seeberger
Journal:  Sci Transl Med       Date:  2017-03-08       Impact factor: 17.956

3.  The innate immune response to Streptococcus pneumoniae in the lung depends on serotype and host response.

Authors:  Beza Seyoum; Masahide Yano; Liise-anne Pirofski
Journal:  Vaccine       Date:  2011-08-22       Impact factor: 3.641

4.  Recurrent pneumococcal invasive disease in the region of Madrid during a five-year period.

Authors:  J C Sanz; I Rodríguez-Avial; E Ríos; B Ramos; E Cercenado
Journal:  Infection       Date:  2013-12-22       Impact factor: 3.553

5.  Serotype 5 pneumococci causing invasive pneumococcal disease outbreaks in Barcelona, Spain (1997 to 2011).

Authors:  Dora Rolo; Asunción Fenoll; Dionísia Fontanals; Nieves Larrosa; Montserrat Giménez; Immaculada Grau; Román Pallarés; Josefina Liñares; Carmen Ardanuy
Journal:  J Clin Microbiol       Date:  2013-08-21       Impact factor: 5.948

6.  An ahemolytic pneumolysin of Streptococcus pneumoniae manipulates human innate and CD4⁺ T-cell responses and reduces resistance to colonization in mice in a serotype-independent manner.

Authors:  M Nadeem Khan; John Robert Coleman; Joshua Vernatter; Avanish Kumar Varshney; Chad Dufaud; Liise-Anne Pirofski
Journal:  J Infect Dis       Date:  2014-06-13       Impact factor: 5.226

7.  Seconeolitsine, the Novel Inhibitor of DNA Topoisomerase I, Protects against Invasive Pneumococcal Disease Caused by Fluoroquinolone-Resistant Strains.

Authors:  Jose Manuel Tirado-Vélez; David Carreño; David Sevillano; Luis Alou; José Yuste; Adela G de la Campa
Journal:  Antibiotics (Basel)       Date:  2021-05-13

8.  Global fluoroquinolone resistance epidemiology and implictions for clinical use.

Authors:  Axel Dalhoff
Journal:  Interdiscip Perspect Infect Dis       Date:  2012-10-14

9.  Emergence of Amoxicillin-Resistant Variants of Spain9V-ST156 Pneumococci Expressing Serotype 11A Correlates with Their Ability to Evade the Host Immune Response.

Authors:  Leire Aguinagalde; Bruno Corsini; Arnau Domenech; Mirian Domenech; Jordi Cámara; Carmen Ardanuy; Ernesto García; Josefina Liñares; Asunción Fenoll; Jose Yuste
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

10.  Impact of preceding flu-like illness on the serotype distribution of pneumococcal pneumonia.

Authors:  Joon Young Song; Moon H Nahm; Hee Jin Cheong; Woo Joo Kim
Journal:  PLoS One       Date:  2014-04-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.